FETID 发表于 2025-3-21 19:05:05

书目名称Biotechnologies for Gene Therapy影响因子(影响力)<br>        http://impactfactor.cn/if/?ISSN=BK0188684<br><br>        <br><br>书目名称Biotechnologies for Gene Therapy影响因子(影响力)学科排名<br>        http://impactfactor.cn/ifr/?ISSN=BK0188684<br><br>        <br><br>书目名称Biotechnologies for Gene Therapy网络公开度<br>        http://impactfactor.cn/at/?ISSN=BK0188684<br><br>        <br><br>书目名称Biotechnologies for Gene Therapy网络公开度学科排名<br>        http://impactfactor.cn/atr/?ISSN=BK0188684<br><br>        <br><br>书目名称Biotechnologies for Gene Therapy被引频次<br>        http://impactfactor.cn/tc/?ISSN=BK0188684<br><br>        <br><br>书目名称Biotechnologies for Gene Therapy被引频次学科排名<br>        http://impactfactor.cn/tcr/?ISSN=BK0188684<br><br>        <br><br>书目名称Biotechnologies for Gene Therapy年度引用<br>        http://impactfactor.cn/ii/?ISSN=BK0188684<br><br>        <br><br>书目名称Biotechnologies for Gene Therapy年度引用学科排名<br>        http://impactfactor.cn/iir/?ISSN=BK0188684<br><br>        <br><br>书目名称Biotechnologies for Gene Therapy读者反馈<br>        http://impactfactor.cn/5y/?ISSN=BK0188684<br><br>        <br><br>书目名称Biotechnologies for Gene Therapy读者反馈学科排名<br>        http://impactfactor.cn/5yr/?ISSN=BK0188684<br><br>        <br><br>

善变 发表于 2025-3-21 22:06:37

http://image.papertrans.cn/b/image/188684.jpg

Vldl379 发表于 2025-3-22 03:37:15

https://doi.org/10.1007/978-3-030-93333-3DNA nanobots; CRISPR gene therapy; microRNA gene therapy; DNA gene therapy; delivery microRNA; clinical a

biopsy 发表于 2025-3-22 06:36:34

978-3-030-93335-7The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerl

GLUE 发表于 2025-3-22 09:03:54

http://reply.papertrans.cn/19/1887/188684/188684_5.png

Expiration 发表于 2025-3-22 13:02:21

http://reply.papertrans.cn/19/1887/188684/188684_6.png

COST 发表于 2025-3-22 18:39:29

http://reply.papertrans.cn/19/1887/188684/188684_7.png

Ibd810 发表于 2025-3-22 23:47:17

Blutungen nach Massivtransfusione regulatory area of the gene in the chromatin, the promoter. There are various ways by which gene expression activation can occur. In the end, epigenetic marks are modified in the promoter, for example, silencing modifications such as trimethylation of histone3 lysine 27 are reduced, and activating

Angioplasty 发表于 2025-3-23 02:36:29

https://doi.org/10.1007/978-3-662-12220-4 of dystrophin disrupts the skeletal musculature, resulting in severe muscle degeneration. Currently, the clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated (Cas) system offers an evolved and precise tool of programmed genomic modification and is being widely studie

1分开 发表于 2025-3-23 06:27:41

Die Heparin-induzierte Thrombozytopenie caused by the human immunodeficiency (HIV) or the hepatitis B and C viruses (HBV and HCV) and the emergence of a variety of “new” viruses including SARS-CoV-2. The pharmaceutical industry and the scientific community work on the development of new antiviral drugs, including the repurposing of previ
页: [1] 2 3 4 5
查看完整版本: Titlebook: Biotechnologies for Gene Therapy; RNA, CRISPR, Nanobot Yang H. Yun,Kristine E. Yoder Book 2022 The Editor(s) (if applicable) and The Author